(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid has been researched along with Vomiting* in 1 studies
1 other study(ies) available for (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Vomiting
Article | Year |
---|---|
Rhabdomyolysis secondary to hyponatraemia.
Topics: Aged; Brain Ischemia; Consciousness Disorders; Dehydration; Diarrhea; Dyslipidemias; Fatty Acids, Monounsaturated; Female; Fluid Therapy; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyponatremia; Indoles; Internal Capsule; Natriuresis; Rhabdomyolysis; Sodium Chloride; Thalamus; Vomiting | 2011 |